We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Metagenomics Enables Rapid Respiratory Infection Testing in ICU Patients

By LabMedica International staff writers
Posted on 28 Feb 2024
Print article
Image: Genetic testing offers potential for faster diagnosis for patients with infectious respiratory conditions (Photo courtesy of 123RF)
Image: Genetic testing offers potential for faster diagnosis for patients with infectious respiratory conditions (Photo courtesy of 123RF)

Patients with respiratory infectious diseases admitted to intensive care units urgently need appropriate medication, yet microbiologists typically require around three days to identify the responsible pathogens. Now, a new technology could offer a faster diagnostic solution for patients struggling with respiratory infections.

Researchers from Guy’s and St Thomas’ NHS Foundation Trust (GSTT, London, UK) have trialed a new technology that accelerates the genetic testing process for patients with suspected respiratory infectious diseases. This advanced approach, known as metagenomics, sequences genetic material from a comprehensive range of microorganisms, including bacteria, viruses, and fungi, potentially responsible for the infection. Remarkably, results are available in just seven hours, enabling same-day administration of accurate and effective treatments.

Unlike other tests, metagenomic testing can detect all present microorganisms, not limited to those specifically being sought or suspected by clinicians of causing the infection. The researchers have secured additional funding to extend this rapid genetic testing to a broader patient base. This expansion builds upon the initial successful pilot, which demonstrated its potential to enhance treatment for nearly half of the participants. The new funding will facilitate the implementation of this technology in multiple hospitals across the UK over the next two years. The aim is to monitor and curtail the spread of respiratory diseases, ultimately aiding in the prevention of new outbreaks.

“It is vital that the sickest patients in our intensive care unit receive the right medication as quickly as possible,” said Ian Abbs, Chief Executive at Guy’s and St Thomas’ and Co-Chair of the South East Genomic Medicine Service. “This new genetic test can make that happen and we are delighted that we now have funding to ensure other intensive care units, and their patients, can also benefit.”

Related Links:
GSTT

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.